FineMark National Bank & Trust’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-200
| Closed | -$6K | – | 373 |
|
|
2016
Q4 | $6K | Hold |
200
| – | – | ﹤0.01% | 1027 |
|
|
2016
Q3 | $6K | Sell |
200
-35
| -15% | -$1.05K | ﹤0.01% | 1032 |
|
|
2016
Q2 | $7K | Sell |
235
-6
| -2% | -$179 | ﹤0.01% | 1009 |
|
|
2016
Q1 | $7K | Buy |
241
+17
| +8% | +$494 | ﹤0.01% | 967 |
|
|
2015
Q4 | $8K | Buy |
224
+12
| +6% | +$429 | ﹤0.01% | 971 |
|
|
2015
Q3 | $7K | Buy |
212
+12
| +6% | +$396 | ﹤0.01% | 1027 |
|
|
2015
Q2 | $8K | Hold |
200
| – | – | ﹤0.01% | 1034 |
|
|
2015
Q1 | $7K | Sell |
200
-49
| -20% | -$1.72K | ﹤0.01% | 1057 |
|
|
2014
Q4 | $8K | Hold |
249
| – | – | ﹤0.01% | 1062 |
|
|
2014
Q3 | $6K | Buy |
249
+19
| +8% | +$458 | ﹤0.01% | 1094 |
|
|
2014
Q2 | $6K | Hold |
230
| – | – | ﹤0.01% | 1128 |
|
|
2014
Q1 | $6K | Hold |
230
| – | – | ﹤0.01% | 1129 |
|
|
2013
Q4 | $6K | Buy |
+230
| New | +$6K | ﹤0.01% | 1114 |
|